These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19080859)

  • 1. [Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency presenting with erythrocytosis].
    Ramos I; Regadera A; Román P; Ezquieta B
    Med Clin (Barc); 2008 Nov; 131(16):638-9. PubMed ID: 19080859
    [No Abstract]   [Full Text] [Related]  

  • 2. Congenital adrenal hyperplasia: diagnostic advances.
    Torresani T; Biason-Lauber A
    J Inherit Metab Dis; 2007 Aug; 30(4):563-75. PubMed ID: 17694353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Müssig K; Kaltenbach S; Maser-Gluth C; Hartmann MF; Wudy SA; Horger M; Gallwitz B; Raue F; Häring HU; Schulze E
    Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):208-14. PubMed ID: 16705555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype.
    Wilson RC; Mercado AB; Cheng KC; New MI
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2322-9. PubMed ID: 7629224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comments to “A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency”.
    Concolino P; Mello E; Rossodivita A; Giardina B; Capoluongo E
    Gene; 2014 Jan; 534(2):449-450. PubMed ID: 24501745
    [No Abstract]   [Full Text] [Related]  

  • 6. Comments to "a rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency".
    Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
    Gene; 2014 Jan; 534(2):451-2. PubMed ID: 24100083
    [No Abstract]   [Full Text] [Related]  

  • 7. A case with combined rare inborn metabolic disorders: congenital adrenal hyperplasia and ornithine transcarbamylase deficiency.
    Kim YM; Lee BH; Choi JH; Kim GH; Lim HH; Yoo HW
    Gene; 2013 Sep; 527(1):394-6. PubMed ID: 23769969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of molecular analysis in the differential diagnosis of congenital 21-hidroxylase deficiency detected in neonatal screening].
    Soriano Guillén L; Velázquez De Cuellar Paracchi M; Ezquieta B
    Med Clin (Barc); 2011 Mar; 136(7):313-4. PubMed ID: 19766262
    [No Abstract]   [Full Text] [Related]  

  • 9. Autopsy diagnosis of 21-hydroxylase deficiency CAH in a case of apparent SIDS.
    Gozzi TG; Harris NP; McGown IN; Cowley DM; Cotterill AM; Campbell PE; Anderson PK; Warne GL
    Pediatr Dev Pathol; 2005; 8(3):397-401. PubMed ID: 16010485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular approaches for the diagnosis of 21-hydroxylase deficiency and congenital adrenal hyperplasia.
    Wedell A
    Clin Lab Med; 1996 Mar; 16(1):125-37. PubMed ID: 8867587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of congenital adrenal hyperplasia and genotype-phenotype correlation.
    Narasimhan ML; Khattab A
    Fertil Steril; 2019 Jan; 111(1):24-29. PubMed ID: 30611409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary: molecular analysis of congenital adrenal hyperplasia in a newborn screening program.
    Killeen AA
    Mol Diagn; 2001 Sep; 6(3):189-91. PubMed ID: 11571712
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of different genotypes on 17-hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Bachega TA; Billerbeck AE; Marcondes JA; Madureira G; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2000 May; 52(5):601-7. PubMed ID: 10792340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Congenital adrenal hyperplasia].
    Bouvattier C; Chatelain P
    Rev Prat; 2008 May; 58(9):990-4. PubMed ID: 18672665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in the pre-screening era.
    Lee CT; Tung YC; Hsiao PH; Lee JS; Tsai WY
    J Formos Med Assoc; 2010 Feb; 109(2):148-55. PubMed ID: 20206839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency.
    Speiser PW; White PC
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):411-7. PubMed ID: 9876336
    [No Abstract]   [Full Text] [Related]  

  • 17. Steroid 21 hydroxylase deficiency congenital adrenal hyperplasia.
    Nimkarn S; Lin-Su K; New MI
    Endocrinol Metab Clin North Am; 2009 Dec; 38(4):699-718. PubMed ID: 19944288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procedure for neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Working Group on Neonatal Screening of the European Society for Paediatric Endocrinology
    Horm Res; 2001; 55(4):201-5. PubMed ID: 11598375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple tumors associated with late-onset congenital adrenal hyperplasia due to aberrant splicing of adrenal 21-hydroxylase gene.
    Boos CJ; Rumsby G; Matfin G
    Endocr Pract; 2002; 8(6):470-3. PubMed ID: 15251833
    [No Abstract]   [Full Text] [Related]  

  • 20. Acne and non-classic congenital adrenal hyperplasia.
    Falhammar H
    N Z Med J; 2008 Jun; 121(1275):94-5. PubMed ID: 18551162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.